Bremer Bank National Association Edwards Lifesciences Corp Transaction History

Bremer Bank National Association

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 07, 2022	SELL	$101.96 - $128.34 $46,595 - $58,651	-457 Reduced 12.79%	3,117 $367,000
Q3 2021 Oct 05, 2021	SELL	$102.91 - $122.75 $56,806 - $67,758	-552 Reduced 13.38%	3,574 $405,000
Q2 2021 Jul 13, 2021	SELL	$83.84 - $104.76 $37,224 - $46,513	-444 Reduced 9.72%	4,126 $427,000
Q4 2020 Jan 12, 2021	SELL	$71.69 - $91.23 $36,776 - $46,800	-513 Reduced 10.09%	4,570 $417,000
Q3 2020 Oct 22, 2020	SELL	$67.19 - $87.44 $29,160 - $37,948	-434 Reduced 7.87%	5,083 $406,000
Q2 2020 Jul 28, 2020	BUY	$57.54 - $76.95 $207,949 - $278,097	3,614 Added 189.91%	5,517 $381,000
Q1 2020 Apr 17, 2020	SELL	$52.41 - $81.0 $6,131 - $9,477	-117 Reduced 5.79%	1,903 $359,000
Q4 2019 Jan 27, 2020	SELL	$71.7 - $82.09 $9,536 - $10,917	-133 Reduced 6.18%	2,020 $472,000
Q3 2019 Oct 03, 2019	SELL	$61.55 - $75.43 $22,958 - $28,135	-373 Reduced 14.77%	2,153 $473,000
Q1 2019 May 09, 2019	BUY	$47.89 - $64.05 $120,970 - $161,790	2,526 New	2,526 $445,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Bremer Bank National Association, based on Form 13F filings with the SEC.

Stay updated on Bremer Bank National Association with notifications on news.